| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |